Skin and Soft Tissue Infection
📧 Sign up to get email alerts when something new happens for Skin and Soft Tissue Infection.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2010-04-27FDA Approved: CEFACLOR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cefaclor by Teva, updating the product labeling.
-
FDA approval · 2010-03-12FDA Approved: CEFOXITIN — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved an original ANDA for cefoxitin by Hikma Pharmaceuticals USA, enabling a generic version of cefoxitin for its indicated infe…
-
CLINICAL_TRIALS trial_result · 2010-01-11Clinical Trial Update: Phase 2 Trial of TD-6424 (Telavancin) Versus Standard Therapy for Complicated Gram Positive Skin and Skin Structure Infections (Gram Positive cSSSI) [Phase 2]
A Phase 2 trial comparing TD-6424 (telavancin) to standard therapy for complicated Gram-positive skin and skin structure infections has comp…
-
FDA approval · 2009-12-22FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma's Ampicillin and Sulbactam as an Original Application (AND A065406), a generic antibiotic combining ampicillin with sulba…
-
CLINICAL_TRIALS trial_result · 2009-10-08Clinical Trial Update: Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers [Phase 1]
Phase 1 multiple ascending-dose study of the antibiotic candidate EDP 322 in healthy adult volunteers has been completed. The study is spons…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-06-26Clinical Trial Update: Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections [Phase 2]
A Phase 2 safety and efficacy study of oxazolidinone antibiotics for uncomplicated skin infections has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: A Study for Patients With Complicated Skin and Skin Structure Infections [Phase 2]
This document reports the completion of a Phase 2 clinical trial for complicated skin and skin structure infections sponsored by Targanta Th…
-
FDA approval · 2007-11-09FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s generic amoxicillin and clavulanate potassium under an Original Application.
-
CLINICAL_TRIALS trial_result · 2007-10-25Clinical Trial Update: A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections [Phase 4]
A Phase 4 trial comparing cefdinir to cephalexin for mild to moderate uncomplicated skin and skin structure infections has completed.
-
FDA approval · 2007-03-26FDA Approved: AMOXICILLIN — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's original application for amoxicillin, making a generic amoxicillin product available. The approval supports its us…
-
FDA approval · 2006-06-19FDA Approved: AMOXICILLIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc. to market amoxicillin under an Original Application (ANDA). The approval covers a generic amoxic…